Fetal Neuroprotection Guidelines

Introduction to Fetal Neuroprotection

Fetal neuroprotection is crucial in high-risk pregnancies, and magnesium sulfate is recommended for this purpose, as supported by the American College of Obstetricians and Gynecologists and the American Heart Association 1, 2, 3

The recommended dosage of magnesium sulfate for fetal neuroprotection is a 4-6g IV loading dose administered over 15-20 minutes, followed by a maintenance infusion of 1-2g/hour until delivery or for a maximum of 24 hours, as recommended by the American College of Obstetricians and Gynecologists 1, 2
For overweight patients (BMI ≥25 kg/m²), higher maintenance doses (2 g/hour) are recommended, as suggested by the American College of Obstetricians and Gynecologists 3, 1
The maintenance dose of magnesium sulfate should be reduced to 0.5-0.75 g/hour (50% reduction from standard dose) for patients with impaired renal function, with close monitoring of serum magnesium levels, deep tendon reflexes, respiratory rate, and urine output, as recommended by the American Heart Association and the American College of Cardiology 4

Magnesium sulfate is recommended for fetal neuroprotection in pregnancies at risk of preterm delivery before 32 weeks of gestation, as supported by the American College of Obstetricians and Gynecologists 2, 5
Magnesium sulfate is also recommended for women with preeclampsia, especially when delivery is anticipated before 32 weeks, as supported by the American College of Obstetricians and Gynecologists and the American Heart Association 1, 3
For preeclampsia with severe hypertension or HELLP syndrome, magnesium sulfate is administered as seizure prophylaxis, with a loading dose of 4-5g IV and a maintenance dose of 1-2g/hour by constant IV infusion, and should be continued for 24 hours postpartum, as recommended by the American Heart Association and the American College of Obstetricians and Gynecologists 6, 1

Clinical signs of magnesium toxicity include ECG interval changes, AV nodal conduction block, bradycardia, hypotension, and loss of tendon reflexes, and should be monitored closely, as described by 7
Clinical assessment for signs of magnesium toxicity should include deep tendon reflexes, respiratory rate, urine output, and level of consciousness, as suggested by the American College of Obstetricians and Gynecologists 1
Calcium chloride (10%) 5-10 mL or calcium gluconate (10%) 15-30 mL should be immediately available to counteract magnesium toxicity, as recommended by 7
Blood pressure should be monitored every 4-6 hours, and hypertension should be treated urgently if BP rises ≥160/110 mmHg, targeting a diastolic BP of 85 mmHg and systolic <160 mmHg, as recommended by the European Society of Cardiology and the American College of Cardiology 1, 8
Total fluid intake should be restricted to 60-80 mL/hour during labor, aiming for euvolemia, as recommended by the American College of Cardiology 1

Laboratory monitoring, including serum magnesium levels, creatinine, liver function tests, platelets, and hemoglobin, should be performed at least twice weekly, as recommended by the National Institute of Health 1
Drugs that may exacerbate hypomagnesemia, such as proton-pump inhibitors, macrolides, fluoroquinolones, gentamicin, and antiviral drugs, should be carefully considered, as they may increase the risk of hypomagnesemia, as recommended by 9
Magnesium supplements are recommended for patients with documented hypomagnesemia, Bartter syndrome, heart failure patients with ventricular arrhythmias, women with preeclampsia or eclampsia, and patients with refractory hypokalemia, as recommended by the American Heart Association and the Kidney International guidelines 10, 9